StonvexLoading…
StonvexCore line items from HP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $3.68B | $2.75B | $2.86B | $2.05B |
Operating Income | $3.32M | $457.45M | $568.31M | $45.29M |
Net Income | $-163.69M | $344.17M | $434.10M | $6.95M |
EPS (Diluted) | $-1.66 | $3.43 | $4.16 | $0.05 |
Total Assets | $6.71B | $5.78B | $4.38B | $4.36B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $196.85M | $217.34M | $257.17M | $232.13M |
Free Cash Flow OCF − CapEx | $116.58M | $189.59M | $438.22M | $-16.98M |
Shares Outstanding | 99.45M | 98.76M | 99.43M | 105.29M |